[Theoretical and practical aspects of uterine contractility inhibition].
D000262:Adenylyl Cyclases / Q000378:metabolism; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000037:antagonists & inhibitors; D000242:Cyclic AMP / Q000378:metabolism; D005260:Female; D009119:Muscle Contraction / Q000187:drug effects; D009124:Muscle Proteins / Q000378:metabolism; D010726:Phosphodiesterase Inhibitors; D011247:Pregnancy; D051381:Rats; D011941:Receptors, Adrenergic / Q000378:metabolism; D014599:Uterus / Q000187:drug effects / Q000294:innervation / Q000378:metabolism / Q000502:physiology*
D000318:Adrenergic beta-Agonists; D009124:Muscle Proteins; D010726:Phosphodiesterase Inhibitors; D011941:Receptors, Adrenergic; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D002118:Calcium
Theoretische und praktische Aspekte der Hemmung der Uteruskontraktilität